Characterization of monoclonal antibodies to Marburg virus (strain Musoke) glycoprotein and identification of two protective epitopes

Virology

Volumn 314, Issue 1, 2003, Pages 350-357

  Hevey, Michael ^a,b   Negley, Diane ^a   Schmaljohn, Alan ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^b National Biodefense Analysis and Countermeasures Center   (United States)

Author keywords

Antibodies; Epitope; Filoviridae; Hemorrhagic fever; Marburg virus; Protection

Indexed keywords

EPITOPE; MONOCLONAL ANTIBODY; VIRUS ANTIBODY; VIRUS GLYCOPROTEIN; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SPECIFICITY; GENE DELETION; GUINEA PIG; IN VITRO STUDY; MARBURG VIRUS; NONHUMAN; PASSIVE IMMUNIZATION; PEPTIDE MAPPING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; VIRUS HEMORRHAGIC FEVER; VIRUS PLAQUE; VIRUS STRAIN;

CAVIA; FILOVIRIDAE; LAKE VICTORIA MARBURGVIRUS; MARBURG VIRUS (STRAIN MUSOKE);

EID: 0141568802     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0042-6822(03)00416-1     Document Type: Article

References (15)

1. Bowen E.T., Lloyd G., Harris W.J., Platt G.S., Baskerville A., Vella E.E. Viral haemorrhagic fever in southern Sudan and northern Zaire. Preliminary studies on the aetiological agent. Lancet. 1:1977;571-573.
2. Feldmann H., Kiley M.P. Classification, structure, and replication of filoviruses. Curr. Top. Microbiol. Immunol. 235:1999;1-21.
3. Feldmann H., Will C., Schikore M., Slenczka W., Klenk H.D. Glycosylation and oligomerization of the spike protein of Marburg virus. Virology. 182:1991;353-356.
4. Hevey M., Negley D., Geisbert J., Jahrling P., Schmaljohn A. Antigenicity and vaccine potential of Marburg virus glycoprotein expressed by baculovirus recombinants. Virology. 239:1997;206-216.
5. Hevey M., Negley D., Pushko P., Smith J., Schmaljohn A. Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates. Virology. 251:1998;28-37.
6. Hevey M., Negley D., VanderZanden L., Tammariello R.F., Geisbert J., Schmaljohn C., Smith J.F., Jahrling P.B., Schmaljohn A.L. Marburg virus vaccines comparing classical and new approaches . Vaccine. 20:2001;586-593.
7. Johnson E.D., Johnson B.K., Silverstein D., Tukei P., Geisbert T.W., Sanchez A.N., Jahrling P.B. Characterization of a new Marburg virus isolated from a 1987 fatal case in Kenya. Arch. Virol. Suppl. 11:1996;101-114.
8. Johnson K.M., Lange J.V., Webb P.A., Murphy F.A. Isolation and partial characterisation of a new virus causing acute haemorrhagic fever in Zaire. Lancet. 1:1977;569-571.
9. Pattyn S., van der Groen G., Courteille G., Jacob W., Piot P. Isolation of Marburg-like virus from a case of haemorrhagic fever in Zaire. Lancet. 1:1977;573-574.
10. Peters C.J., LeDuc J.W. An introduction to Ebola the virus and the disease . J. Infect. Dis. 179:(Suppl. 1):1999;ix-xvi.
11. Siegert R., Shu H.L., Slenczka W. [Isolation and identification of the "Marburg virus"]. Dtsch. Med. Wochenschr. 93:1968;604-612.
12. Slenczka W., Shu H.L., Piepenburg G., Siegert R. ["Marburg virus" antigen demonstration by immunofluorescence in the organs of infected guinea pigs]. Dtsch. Med. Wochenschr. 93:1968;612-616.
13. Slenczka W.G. The Marburg virus outbreak of 1967 and subsequent episodes. Curr. Top. Microbiol. Immunol. 235:1999;49-75.
14. Smith D.H., Johnson B.K., Isaacson M., Swanapoel R., Johnson K.M., Killey M., Bagshawe A., Siongok T., Keruga W.K. Marburg-virus disease in Kenya. Lancet. 1:1982;816-820.
15. Wilson J.A., Bray M., Bakken R., Hart M.K. Vaccine potential of Ebola virus VP24, VP30, VP35, and VP40 proteins. Virology. 286:2001;384-390.